1. Molecular Neurobiology Group, Instituto de Biologia Molecular e Celular (IBMC) – Instituto de Investigação e Inovação em Saúde (i3S) da Universidade do Porto, Porto, Portugal;
2. Neurology Department, Centro Hospitalar Universitário do Porto (CHUP), Porto, Portugal;
3. Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal;
4. Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland;
5. Neurology Department, Centro Hospitalar Universitário Lisboa Norte (CHULN) and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;
6. Amyloidosis Research and Treatment Centre, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
7. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy